0001127602-21-024865.txt : 20210903
0001127602-21-024865.hdr.sgml : 20210903
20210903160919
ACCESSION NUMBER: 0001127602-21-024865
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210901
FILED AS OF DATE: 20210903
DATE AS OF CHANGE: 20210903
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: APPIO THOMAS
CENTRAL INDEX KEY: 0001683323
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14956
FILM NUMBER: 211236577
MAIL ADDRESS:
STREET 1: 400 SOMERSET CORPORATE BOULEVARD
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Bausch Health Companies Inc.
CENTRAL INDEX KEY: 0000885590
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2150 ST. ELZEAR BLVD. WEST
STREET 2: LAVAL
CITY: QUEBEC
STATE: A8
ZIP: H7L 4A8
BUSINESS PHONE: 514-744-6792
MAIL ADDRESS:
STREET 1: 2150 ST. ELZEAR BLVD. WEST
STREET 2: LAVAL
CITY: QUEBEC
STATE: A8
ZIP: H7L 4A8
FORMER COMPANY:
FORMER CONFORMED NAME: Valeant Pharmaceuticals International, Inc.
DATE OF NAME CHANGE: 20100928
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL Corp
DATE OF NAME CHANGE: 20100416
FORMER COMPANY:
FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL
DATE OF NAME CHANGE: 19960522
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2021-09-01
0000885590
Bausch Health Companies Inc.
BHC
0001683323
APPIO THOMAS
400 SOMERSET CORPORATE BOULEVARD
BRIDGEWATER
NJ
08807
1
Pres&Co-Head Bausch&Lomb/Int'l
Common Shares, No Par Value
2021-09-01
4
A
0
90260
0
A
320686
D
Restricted Share Units
0
2021-09-01
4
A
0
90260
0
A
Common Shares, No Par Value
90260
90260
D
Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of the Issuer ("Common Shares").
Represents a grant of performance-based RSUs ("PSUs"), each of which represents a contingent right to receive one Common Share. The number of Common Shares to be distributed upon the vesting of the PSUs will be determined by the Issuer's Total Shareholder Return ("TSR"), as measured for the 20 trading days preceding the TSR measurement date, and will be between 0% to 200% of the PSU target reported in Column 5.
/s/ Kirsten O'Donnell, attorney-in-fact for Thomas Appio
2021-09-03